Haloperidol/sodium valproateNeuroleptic malignant syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1521卷 / 1期

关键词：

D O I：

10.1007/s40278-014-3886-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：81 / 81

相关论文

共 50 条

[1] Fluphenazine/sodium-valproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2021, 1878 (1) : 248 - 248
[2] ValproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2017, 1649 (1) : 245 - 245
[3] Haloperidol/olanzapine/valproateNeuroleptic malignant syndrome and bone marrow suppression: case report
Reactions Weekly, 2015, 1559 (1) : 85 - 85
[4] Thioridazine/valproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2012, 1413 (1) : 43 - 43
[5] Antipsychotics/valproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2020, 1814 (1) : 75 - 75
[6] Olanzapine/sodium valproateNeuroleptic malignant syndrome and syndrome of inappropriate antidiuretic hormone: case report
Reactions Weekly, 2013, 1475 (1) : 29 - 29
[7] Tozinameran/valproateNeuroleptic malignant syndrome and adrenal insufficiency: case report
Reactions Weekly, 2022, 1909 (1) : 534 - 534
[8] Clozapine/aripiprazole/risperidone/valproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2009, 1236 (1) : 14 - 14
[9] Olanzapine/valproateNeuroleptic malignant syndrome and increased serum ammonia: case report
Reactions Weekly, 2014, 1500 (1) : 29 - 29
[10] Haloperidol/olanzapineNeuroleptic malignant syndrome: case report
Reactions Weekly, 2022, 1931 (1) : 285 - 285

← 1 2 3 4 5 →